Stefan Larson is an Entrepreneur-in-Residence at Versant Ventures, where he serves as President of Blueline Bioscience, a Toronto-based biotechnology incubator. He is also the founding CEO of Northern Biologics, an antibody discovery company located in the MaRS Centre. Stefan joined Versant after spending three years as the co-founder and CEO of Tornado Medical Systems, a revenue-stage medical imaging and spectroscopy company. He previously held the position of Associate Principal with McKinsey & Company, serving global clients in healthcare and technology. He is currently a director of the Ontario Bioscience Innovation Organization (OBIO) and is a recipient of the Arbor Award for Exceptional Volunteer Service to the University of Toronto. Stefan received his B.Sc. in Biology from McGill University, and his M.Sc. in Molecular and Medical Genetics from the University of Toronto. He completed his Ph.D. in Biophysics at Stanford University, where he helped build and launch Folding@home, the world’s most successful scientific public distributed computing platform.